|
|
CFC content in 100 fresh, Day 0, (n=6) or the equivalent of 100 Rholo cells after 35 days of culture (n=8). The frequency of LT-CRSC of freshly purified Rholo cells, 1 in 14, compared to the frequency of CAFC, 1 in 13±1.7 (n=11), after 28-35 days culture on AFT024. Limiting-dilution CRSC and CAFC frequency was determined by Poisson statistics at 37% negative mice or wells. Rholo cells from the same purification were used to determine both CRSC and CAFC frequencies. %Ly5.2 peripheral blood cells from 25 Day 0 Rholo cells (n=5) compared to the 35 day cultured equivalent of 25 Rholo cells (n=5) from the same purification; both transplanted in CRSC assay.
Expression arrays developed from the AFT024-subtracted library were interrogated with probes derived from stromal cell lines. A clustering algorithm was used to profile the data and informative clusters were selected. The contents of the clusters revealed in the cDNA microarray (StroChip) analysis were compared to those selected in the custom filter array analysis. The overlapping gene products are displated as their relative signal to background ratios in red to green coloration for both the StroChip (left panel) and filter arrays (right panel). The Pearson correlation coefficient (r) of this subset of gene products for each line compared to AFT024 is; 2012 (0.32), 2058 (0.42), and 2018 (0.04). Tables of correlation coefficients of all array elements and comparisons are shown below the gene expression images.
The ability of stromal cell lines to support enriched stem cell populations was studied. A. Limiting-dilution CAFC assay on each stroma at 4 weeks. B. Stem cells were cultured on each stroma and then after 4 weeks replated into limiting-dilution CAFC assay onto fresh AFT024 monolayers. This assay determines the ability of each stroma to maintain stem cells with a capacity to generate secondary CAFC. Limiting-dilution frequency was determined at 37% negative wells according to Poisson statistics and is shown in parentheses for both graphs. The ability of each line to maintain stem cells in the secondary CAFC assay relative to AFT024 is; 2012 (32%), 2058 (31%), and 2018 (1%). These data correlate well with the results from the gene expression analysis in Figure 4.